{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:18:36Z","timestamp":1775899116513,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1989]]},"DOI":"10.1007\/bf00689575","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T13:03:32Z","timestamp":1101819812000},"page":"156-160","source":"Crossref","is-referenced-by-count":7,"title":["Protection against cisplatin nephrotoxicity by prochlorperazine"],"prefix":"10.1007","volume":"25","author":[{"given":"R. A.","family":"Kramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"391","volume-title":"The pharmacologic basis of therapeutics","author":"RJ Baldessarini","year":"1980","unstructured":"Baldessarini RJ (1980) Drugs and the treatment of psychiatric disorders. In: Goodman Gilman AF, Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics, 6th edn. MacMillan, New York, pp 391?447","edition":"6th edn."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1200\/JCO.1985.3.8.1127","volume":"3","author":"B Carr","year":"1985","unstructured":"Carr B, Bertrand M, Browning S, Dorowshow JH, Presant C, Pulone B, Hill LR (1985) A comparison of the antiemetic efficacy of prochlorperazine and metoclopromide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study. J Clin Oncol 3: 1127?1132","journal-title":"J Clin Oncol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0009-2797(81)90009-0","volume":"35","author":"WC Cole","year":"1981","unstructured":"Cole WC, Wolf W (1981) Renal toxicity of protein-bound platinum. Chem-Biol Interact 35: 341?348","journal-title":"Chem-Biol Interact"},{"key":"CR4","first-page":"319","volume":"53","author":"L Gailis","year":"1986","unstructured":"Gailis L (1986) Protection against doxorubicin toxicity in mice by chlorpromazine hypothermia. Res Commun Chem Pathol Pharmacol 53: 319?330","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1986.4.6.994","volume":"4","author":"WN Hait","year":"1986","unstructured":"Hait WN, Lazo JS (1986) Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol 4: 994?1012","journal-title":"J Clin Oncol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00257241","volume":"10","author":"SD Harrison","year":"1982","unstructured":"Harrison SD, Coox JL, Giles RC (1982) Effects of prochlorperazine on experimental nephrotoxicity. Cancer Chemother Pharmacol 10: 62?67","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF01609757","volume":"34","author":"SD Harrison","year":"1985","unstructured":"Harrison SD, Cox JL, Giles RC (1985) Inhibition effects of calmodulin antagonists on urinary enzyme excretion in rats after nephrotoxic doses of mercuric chloride. Bull Environ Contam Toxicol 34: 432?437","journal-title":"Bull Environ Contam Toxicol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF00434354","volume":"14","author":"SD Harrison","year":"1985","unstructured":"Harrison SD, Mann DM, Giles RC (1985) Effect of nitrosoureas on calmodulin activity in vitro and in mouse intestine in vivo. Cancer Chemother Pharmacol 14: 146?149","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","volume":"39","author":"DM Hayes","year":"1977","unstructured":"Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH (1977) High dose cis-platinum diamminedichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39: 1372?1381","journal-title":"Cancer"},{"key":"CR10","first-page":"459","volume":"57","author":"DJ Higby","year":"1973","unstructured":"Higby DJ, Wallace HJ, Holland JF (1973)cis-diamminedichloroplatinum (NSC-119875): a phase I study. Cancer Chemother Rep 57: 459?463","journal-title":"Cancer Chemother Rep"},{"key":"CR11","first-page":"436A","volume":"26","author":"EF Holdener","year":"1978","unstructured":"Holdener EF, Park CH, Belt RJ, Stephens RL, Hoogstraten B (1978) Effect of manitol and human plasma on cytotoxicity ofcis-diamminedichloroplatinum. Clin Res 26: 436A","journal-title":"Clin Res"},{"key":"CR12","first-page":"409","volume":"22","author":"RA Kramer","year":"1983","unstructured":"Kramer RA, Boyd MR (1983) Nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) in the Fisher 344 rat. J Pharmacol Exp Ther 22: 409?414","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM198110153051609","volume":"305","author":"J Laszlo","year":"1981","unstructured":"Laszlo J, Lucas VS (1981) Emesis as a critical problem in chemotherapy. N Engl J Med 305: 948?949","journal-title":"N Engl J Med"},{"key":"CR14","first-page":"387","volume":"27","author":"JS Lazo","year":"1985","unstructured":"Lazo JS, Hait WN, Kennedy KA, (1985) Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists. Mol Pharmacol 27: 387?393","journal-title":"Mol Pharmacol"},{"key":"CR15","first-page":"285","volume":"42","author":"PD Leathwood","year":"1974","unstructured":"Leathwood PD, Gilford MK, Plummer DT (1974) Enzymes in rat urine: lactate dehydrogenase. Enzymologia 42: 285?321","journal-title":"Enzymologia"},{"key":"CR16","first-page":"2340","volume":"36","author":"CL Litterst","year":"1976","unstructured":"Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM (1976) Distribution and disposition of platinum following intravenous administration ofcis-diamminedichloroplatinum(II) (NSC 119875) to dogs. Cancer Res 36: 2340?2344","journal-title":"Cancer Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(78)90825-2","volume":"65","author":"NE Madias","year":"1973","unstructured":"Madias NE, Harrington JT (1973) Platinum nephrotoxicity. Am J Med 65: 307?314","journal-title":"Am J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jnci\/80.18.1486","volume":"80","author":"R Qazi","year":"1988","unstructured":"Qazi R, Chang AYC, Borch RF, Montine T, Dedon P, Lougher J, Bennett JM (1988) Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J Natl Cancer Inst 80: 1486?1488","journal-title":"J Natl Cancer Inst"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","volume":"222","author":"B Rosenberg","year":"1969","unstructured":"Rosenberg B, VanCamp L, Trosko FQ (1969) Platinum compounds: a new class of potent antitumor agents. Nature 222: 385?386","journal-title":"Nature"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cpt1978234461","volume":"23","author":"JJ Stark","year":"1978","unstructured":"Stark JJ, Howell SB (1978) Nephrotoxicity of cis-platinum(II) dichlorodiammine. Clin Pharmacol Ther 23: 461?466","journal-title":"Clin Pharmacol Ther"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00000421-198712000-00012","volume":"10","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Verma S, Maroun JA (1987) Phase I study of the combination of disulfiram with cisplatin. Am J Clin Oncol 10: 517?519","journal-title":"Am J Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/0006-2952(82)90104-6","volume":"31","author":"B Weiss","year":"1982","unstructured":"Weiss B, Prozialeck WC, Wallace TL (1982) Interaction of drugs with calmodulin. Biochem Pharmacol 31: 2217?2226","journal-title":"Biochem Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00689575\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00689575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T18:40:53Z","timestamp":1554835253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00689575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989]]}},"alternative-id":["BF00689575"],"URL":"https:\/\/doi.org\/10.1007\/bf00689575","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989]]}}}